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Interactions among multiple genes across the genome may con-
tribute to the risks of many complex human diseases. Whole-genome
single nucleotide polymorphisms (SNPs) data collected for many thou-
sands of SNP markers from thousands of individuals under the case–
control design promise to shed light on our understanding of such
interactions. However, nearby SNPs are highly correlated due to link-
age disequilibrium (LD) and the number of possible interactions is
too large for exhaustive evaluation. We propose a novel Bayesian
method for simultaneously partitioning SNPs into LD-blocks and se-
lecting SNPs within blocks that are associated with the disease, ei-
ther individually or interactively with other SNPs. When applied to
homogeneous population data, the method gives posterior probabili-
ties for LD-block boundaries, which not only result in accurate block
partitions of SNPs, but also provide measures of partition uncer-
tainty. When applied to case–control data for association mapping,
the method implicitly filters out SNP associations created merely by
LD with disease loci within the same blocks. Simulation study showed
that this approach is more powerful in detecting multi-locus associ-
ations than other methods we tested, including one of ours. When
applied to the WTCCC type 1 diabetes data, the method identified
many previously known T1D associated genes, including PTPN22,
CTLA4, MHC, and IL2RA. The method also revealed some interest-
ing two-way associations that are undetected by single SNP methods.
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Most of the significant associations are located within the MHC re-
gion. Our analysis showed that the MHC SNPs form long-distance
joint associations over several known recombination hotspots. By con-
trolling the haplotypes of the MHC class II region, we identified addi-
tional associations in both MHC class I (HLA-A, HLA-B) and class
III regions (BAT1 ). We also observed significant interactions between
genes PRSS16, ZNF184 in the extended MHC region and the MHC
class II genes. The proposed method can be broadly applied to the
classification problem with correlated discrete covariates.
1. Introduction. A recent genome-wide association (GWA) study of
14,000 cases of seven human genetic diseases and 3,000 shared controls by
the Welcome Trust Case Control Consortium [WTCCC (2007)] represents
a thorough validation of the GWA approach. By testing hundreds of thou-
sands of single nucleotide polymorphisms (SNPs) in the human population
(Affymetrix 500k SNP), the study has identified many SNPs associated with
seven complex diseases [WTCCC (2007)]. Each SNP consists of two alle-
les taking values 0 or 1, and there are three possible combinations of the
two alleles: (0,0), (0,1), (1,1), disregarding the order. Each combination is
called a genotype, representing wild homozygote, heterozygote, and mutant
homozygote, respectively. In a case–control study, a SNP is said to be asso-
ciated with the disease if the genotype (or allele) distribution at the SNP is
different between cases and controls. In addition to testing individual SNPs,
it has also been anticipated that epistatic interactions among SNPs, defined
as multiple SNPs jointly associated with the disease, may be responsible
for significantly elevating the risks of some human complex diseases. Due to
computational and methodological limitations, however, efforts on detect-
ing disease-related epistatic interactions among SNPs in the WTCCC study
have been limited.
In the past few years, many approaches have been developed for case–
control studies to detect epistasis associations. Most methods cannot be
applied to GWA studies due to their computational limitations except for
some recently developed methods, such as the stepwise logistic regression
method [Marchini, Donnelly and Cardon (2005)] and the Bayesian epistasis
association mapping (BEAM) algorithm [Zhang and Liu (2007)]. It has been
demonstrated that BEAM is capable of detecting high-order interactions in
GWA studies and is more powerful than other existing methods [Zhang and
Liu (2007)]. A limitation of BEAM, however, is its model assumption that
a Markov chain can capture the dependence structure of the SNPs in the
data. It is well known that linkage disequilibrium (LD) between adjacent
SNPs exhibits block-wise structure in the human genome [The International
HapMap Consortium (2005), Reich et al. (2001)]. SNPs within blocks are
highly correlated and the correlation is broken down by recombination events
at block boundaries. A simple Markov model cannot capture this important
block structure when analyzing dense SNPs.
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Previous studies have shown that using haplotypes, defined as allele combi-
nations over multiple nearby SNPs inherited from one of the parents, cannot
only reduce the high computation cost in GWA studies, but also improve
the detection power of association mapping [Kuno et al. (2004); Zo¨llner and
Pritchard (2005); Johnson et al. (2001); Zhang et al. (2002a); de Bakker et
al. (2005)]. In particular, Nielsen et al. (2004) showed that when moder-
ate to high levels of LD exist, haplotype tests tend to be substantially more
powerful. Kuno et al. (2004) demonstrated in a real disease study that single-
SNP tests were not significant even at SNP loci close to the mutation site
(APRT*J), whereas the haplotype block data yielded sufficient statistical
significance.
Similar to haplotypes, we define diplotypes as genotype combinations over
multiple nearby SNPs. Diplotypes are directly observed in GWA studies,
whereas haplotypes have to be inferred using computationally expensive
algorithms. Throughout the paper, we discuss our method and results on
diplotype associations with the disease, although the method is directly ap-
plicable to haplotype data. Our focus on diplotype association is mainly due
to the computational concern, where inferring unobserved haplotypes will be
extremely time consuming. It is also possible that testing diplotype associa-
tions could be more powerful than testing haplotype associations, depending
on the underlying disease model. On the other hand, if haplotype associa-
tions are of the interests, users can first infer haplotypes using an available
haplotype inference algorithm, and then input the inferred haplotypes into
our method. The degrees of freedom of our model will automatically accom-
modate the different inputs.
In this paper we extend the BEAM model to address the block struc-
tures in the human genome. We refer to SNP block structures as LD-blocks.
By partitioning SNPs into LD-blocks, a na¨ıve extension of BEAM is to
treat each LD-block as a genetic marker, with diplotypes in the block being
treated as alleles. This approach, however, may not be optimal for asso-
ciation mapping. First, criteria utilized in existing block-partitioning algo-
rithms do not directly aim at optimizing the power of association mapping.
Second, many regions in the human genome demonstrate vague structural
patterns, of which a measure of uncertainty in block structures should be
provided. Simulation studies have shown that LD-block structures can be
affected by marker density [Wang et al. (2002); Pillips et al. (2003); Wall
and Pritchard (2003)], population structure [Wang et al. (2002); Stumpf
and Goldstein (2003); Zhang et al. (2003); Anderson and Slatkin (2004)],
and gene conversion [Przeworski and Wall (2001)].
We propose a Bayesian model to simultaneously infer LD-blocks and select
SNPs within blocks for disease association mapping. The model partitions
the genome into discrete blocks, within which the diversity of diplotypes is
limited. Block structures are iteratively updated such that disease associa-
tions are detected and summarized from a variety of likely block partitions.
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This approach takes into account the uncertainty in block structures and
optimizes the detection power by searching for the best partitions around
disease-associated SNPs. Our method detects combinations of SNPs within
and between blocks for marginal and epistatic associations to the disease
status. Using LD-blocks, our method also automatically filters out artifi-
cial associations created merely by LD with nearby authentically associated
SNPs. We show that the new method, BEAM2, is more powerful than the
original BEAM (renamed BEAM1 henceforth).
By applying BEAM2 to the type 1 diabetes (T1D) data from WTCCC
(2007), we obtained all the previously identified single SNP associations in
the WTCCC T1D data. We further observed some interesting two-way joint
associations not detectable by single-SNP methods. The strongest T1D asso-
ciations occur in the well-known Major Histocompatibility Complex (MHC)
region, in which we observed long-distance joint association patterns over
several millions of base pairs (Mb). Since this pattern may be partially
caused by the extended LD from the MHC class II region, we further con-
trolled the structure of MHC class II using a logistic regression model, and
tested additional effects of SNPs over the extended MHC region as well as
the MHC class I and class III regions. We observed strong associations in
the MHC class I and class III regions, and found significant interaction asso-
ciations between genes PRSS16, ZNF184 in the extended MHC region and
the MHC class II genes.
The article is organized as follows. In Section 2 we first introduce a LD-
block model for the genotype distribution among multiple SNPs. We model
the genotype distribution within a block of SNPs by multinomial distribu-
tions and assume that the joint distribution of all SNPs is the product of
the distributions of individual blocks (i.e., assuming block independence).
In Section 3 we extend the LD-block model to incorporate disease associ-
ated SNPs and epistasis and describe Monte Carlo Markov chain (MCMC)
algorithms to make inference from the joint model for both LD-blocks and
disease associations. In Section 4 we briefly review our previously developed
Bayes factor-based test statistic, which is used to further evaluate the sta-
tistical significance of candidate epistasis detected by BEAM2, and discuss
extensions of BEAM and BEAM2 for general classification problems. In Sec-
tion 5 we demonstrate the superior performance of BEAM2 by simulation
studies and real data applications. In Section 6 we report our results from
applying BEAM2 to the T2D data from WTCCC (2007). We conclude the
article with a short discussion in Section 7. More implementation details can
be found in Supplemental Material [Zhang, Zhang and Liu (2011)].
2. A Bayesian model for LD-block inference. The data of interest consist
of genotypes at a total of L SNP markers (or L covariates, each taking on
3 possible values) observed in Nd case and Nu control individuals. Let D=
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(D1, . . . ,DL) denote a Nd×Lmatrix of case genotypes, and U = (U1, . . . ,UL)
denote a Nu×Lmatrix of control genotypes, whereDi and Ui denote vectors
of genotypes observed at SNP i across individuals.
2.1. Bayesian LD-block model. Here we introduce a Bayesian LD-block
partition model without considering disease association. Hence, we treat
cases (D) and controls (U) as coming from the same population and use
the combined data (D,U ) to describe the model. A diplotype for an LD-
block of SNPs is defined as a particular genotype combination of all the
SNPs in that block. We seek to partition the L markers into B consecu-
tive blocks, so that the number of observed diplotypes within each block is
small (strong correlation), and correlation between SNPs in different blocks
is weak. Block partitions can be quite ambiguous in many genomic regions
and can vary across samples in details. Diplotype block structures obtained
from available software are often based on ad hoc criteria that neither re-
sult in a proper uncertainty measure nor optimize the association mapping
power.
The block variable B in our model consists of L binary indicators corre-
sponding to the L SNPs in the data. An indicator is equal to 1 if the corre-
sponding SNP is the start position of a block, and 0 otherwise. As a result, B
uniquely defines a partition of SNPs into consecutive blocks. For a diplotype
block [a, b) consisting of SNPs a, . . . , b−1, we let (nh,mh) denote the counts
of a particular diplotype h in cases and controls, respectively. There are 3b−a
possible diplotypes in the block. We assume that the diplotype of each indi-
vidual follows independently from a multinomial distribution with frequency
parameters {ph}, and {ph} follows a Dirichlet prior distribution, Dir({αh}),
where {αh} denotes a hyper-parameter (i.e., pseudo-counts). More precisely,
letting {nh +mh} denote the combined counts of diplotype h observed in
cases and controls, we have
Pr({nh+mh}|{ph}) =
3b−a∏
h=1
pnh+mhh and Pr({ph}) =
Γ(α•)∏3b−a
h=1 Γ(αh)
3b−a∏
h=1
pah−1h ,
where the subscript ‘•’ denotes the sum of values over all subscripts. We can
integrate out {ph} by∫
Pr({nh +mh}|{ph})Pr({ph})d({ph})
=
Γ(α•)∏d−1
h=1Γ(αh)
∫ 3b−a∏
h=1
pnh+mh+αh−1h d({ph}).
Noting that the integrant on the right-hand side is proportional to the den-
sity function of Dir(nh+mh+αh) up to its normalizing constant, we obtain
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the marginal probability of the combined data of block [a, b) as
P (D[a,b),U[a,b)|[a, b) forms a block)
(1)
=
(
3b−a∏
h=1
Γ(nh +mh +αh)
Γ(αh)
)
Γ(α•)
Γ(n• +m• + α•)
.
We set αh = ρ/3
b−a for diplotype h, and by default, we let ρ= 1.5. Based
on the likelihood equivalence principle [Heckerman, Geiger and Chickering
(1995)], {αh} is chosen to be inversely proportional to the total number of
possible diplotypes in a block, and, hence, the sum α• remains a constant
over different block sizes. Note that formula (1) can also be used to model ca-
se data (D) or control data (U) only, which is simply done by letting mh = 0,
or nh = 0, respectively, for all h. Further assuming independence between
blocks (which is not entirely true, but serves as a good approximation), the
probability function P (D,U |B) of genotypes of all blocks can be expressed
as the product of individual block probabilities defined in formula (1).
2.2. Bayesian inference of SNP association based on blocks. A saturated
test of disease association for a diplotype block of Mz consecutive SNPs
involves 3M − 1 free parameters. When M is moderately large (M > 3), the
power of the test becomes exceedingly low. We propose a Bayesian model
of disease associations using only a subset of markers in the block. Here, we
only discuss joint associations for SNPs within a diplotype block, and we
will address epistatic interactions in the next section. It therefore suffices to
describe our model for only one block.
Let {M} denote the set of M SNPs in the block. We assume that only
a subset {x} of SNPs of size x (often is 0 or 1) are truly associated with
the disease, and the SNPs in {M}\{x} are not associated with the disease
given {x}. Thus, the diplotypes of SNPs in {x} are distributed differently
and hence are modeled by two different distributions for cases and controls,
respectively. Conditional on the diplotypes of SNPs in {x}, the diplotypes of
SNPs in {M}\{x}, however, follow a common distribution between cases and
controls. The joint probability of the block data can therefore be expressed as
P (D{M},U{M}) = P (D{x})P (U{x})P (D{M}\{x},U{M}\{x}|D{x},U{x}).(2)
Here, P (D{x}) and P (U{x}) are modeled by two independent multinomial-
Dirichlet distributions specified in formula (1), treating all SNPs in {x}
jointly as a block. To model P (D{M}\{x},U{M}\{x}|D{x},U{x}), we combine
the diplotypes of SNPs in {M}\{x} in cases and controls together. These
diplotypes are not directly associated with the disease given {x}, and thus
have the same conditional distributions between cases and controls. Condi-
tional on each possible diplotype h of SNPs in {x}
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diplotype distribution of SNPs in {M}\{x} again by a multinomial-Dirichlet
distribution. It is straightforward to derive the expression
P (D{M}\{x},U{M}\{x}|D{x},U{x}) = P (D{M},U{M})/P (D{x},U{x}),
where P (D{M},U{M}) and P (D{x},U{x}) are specified in formula (1), treat-
ing {M} and {x} as blocks, respectively. We note, however, that the marker
set {x} is unknown a priori, and needs to be inferred jointly with other
parameters in our Bayesian model.
3. Joint inference of diplotype blocks and disease association.
3.1. The joint model. To further incorporate epistatic interactions in for-
mula (2), and to identify which SNPs are associated with the disease (re-
sponse), we partition all SNPs (not blocks) into three groups as in BEAM
[Zhang and Liu (2007)]. We introduce a latent L-dimensional indicator vari-
able (I) to represent the group memberships of the L markers. For each
marker i, Ii = 0,1,2 denotes three possible group memberships. SNPs be-
longing to group-2 are assumed to be jointly associated with the disease,
that is, epistasis, which are modeled by two joint multinomial distributions
on the diplotypes over all group-2 SNPs—one for cases and one controls.
SNPs belonging to group-1 are assumed to be marginally associated with
the disease if they belong to different blocks, and are modeled by mutually
independent multinomial distributions conditional on the case–control sta-
tus and the block structure. If multiple group-1 SNPs fall into one block,
we model their diplotypes jointly, that is, group-1 SNPs within blocks be-
come dependent of each other. If there are both group-1 and group-2 SNPs
within one block, we model the diplotypes of group-1 SNPs within the block
conditional on the diplotypes of the group-2 SNPs within the block. SNPs
belonging to group-0 are the remaining SNPs unrelated to the disease status.
We again model the distribution of group-0 SNPs within a block by multi-
nomial distributions, with common parameters for cases and controls. We
further assume conditional independence of group-0 SNPs between blocks,
conditional on the group-1 and group-2 SNPs. More precisely, within each
block, we let {x2} denote the set of group-2 SNPs, let {x} denote the union
of the group-1 and group-2 SNPs, and let {M} denote all SNPs. We revise
formula (2) to take the form of a conditional probability function:
P (D{M}\{x2},U{M}\{x2}|D{x2},U{x2})
(3)
=
P (D{x})P (U{x})P (D{M}\{x},U{M}\{x}|D{x},U{x})
P (D{x2})P (U{x2})
.
Thus, group-0 and group-1 SNPs are no longer mutually independent as in
BEAM1, but are related to each other via the block structure. With epistasis
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considered, the mutual independence between blocks in model (2) becomes
conditional independence given group-2 SNPs. For notational simplicity, we
omit variable I in (3), but both {x} and {x2} are determined by I .
Given a particular block partition B and SNP group memberships I , we
express the joint probability function of the entire case–control data as
P (D,U |B,I) = P (D2|B,I)P (U2|B,I)
(4)
×
∏
{M}=[a,b)∈B
P (D{M}\{x2},U{M}\{x2}|D{x2},U{x2},B, I),
where D2 and U2 denote the case and control genotypes of group-2 SNPs,
respectively, and the product term is defined in formula (3).
3.2. Choice of prior distributions. We set the prior distribution of the
block variable B as the product of independent Bernoulli probabilities P (B)=
p|B|(1− p)L−|B|, where |B| denotes the sum of indicators in B. According
to the block distributions estimated in European and Asian populations by
Gabriel et al. (2002), we assume that there are 50,000 blocks in the human
genome a priori, and thus we set p=min(0.5,50,000R/(3× 109L)). Here, R
denotes the length of the region spanned by the L SNPs, and 3 × 109 is
the length of the human genome. A smaller value of p will help the method
identify larger blocks, and a larger p will tend to identify smaller blocks.
As the sample size (number of individuals) increases, however, the impact
of the prior choices diminishes quickly. To avoid overfitting the blocks, we
further impose a restriction that the maximum number of observed distinct
diplotypes in a block must be smaller than (Nd +Nu)/10.
We set the prior distribution of the SNP membership variable I as a prod-
uct of independent multinomial distributions, P (I) =
∏2
i=0 p
|{j:Ij=i}|
i , where
{p0, p1, p2} denote the prior probability of each SNP belonging to group
0, 1, and 2, respectively. By default, we set p1 = p2 = min(0.1,5/L), and
p0 = 1− p1 − p2. That is, we assume there are 10 SNPs associated with the
disease a priori, where 5 are marginally associated with the disease, and 5 are
associated through epistasis. Our choice of the prior reflects that there are
just a few SNPs truly associated with the disease in a GWA study (where
many other significant SNPs are due to LD effects). Increasing this prior
(and also increasing the significance level) in the BEAM2 program may help
identify additional SNPs of moderate to low effects. To avoid overfitting in
interaction mapping, we further set an upper bound to the order of interac-
tions by ln3((Nd+Nu)/10). For example, when the sample size is 1,000, our
method can detect up to 4-way interactions. Overall, changing the values
of p1, p2 may affect the posterior distribution of SNPs in groups 1 and 2,
but the effects will diminish as the sample size increases.
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Finally, the joint model of the observed genotype data in cases (D) and
controls (U ), the block variable (B), and the SNP membership (I), is writ-
ten as
P (D,U,B, I) = P (D,U |B,I)P (B)P (I),(5)
where the conditional distribution of (D,U ) given (B,I) is specified in for-
mula (4).
3.3. MCMC updates. The parameters of interest in our model are the
block partition B and SNP membership I . We develop Metropolis–Hastings
(MH) algorithms [Liu (2001)] to update B, and, simultaneously, we develop
a mix of a Gibbs sampler and Metropolis–Hastings algorithm to update I .
The posterior distribution of (B,I) is then output for further analysis.
To explore all possible block partitions, we propose the following MH-mo-
ves: given a current block configuration B, we randomly select a block and
(1) divide the block into two new blocks at a random position;
(2) merge two adjacent blocks into one block; and
(3) randomly shift a block boundary to either left or right by k SNPs,
where the shifting amount is constrained by other block boundaries.
The proposed move produces a new block partition B′, and the move is
accepted with probability r =min{1, P (D,U,I,B
′)q(B′→B)
P (D,U,I,B)q(B→B′) }, where q(B→ B
′)
denotes the probability of updating from B to B′, and P (D,U,B, I) is cal-
culated from the full model (5). In our implementation, we chose the three
types of MH moves with probabilities 0.1, 0.1, and 0.8, respectively, and we
require a block to contain at least one SNP.
To update the SNPmembership variable I , we updated the membership Ii
of SNP i by calculating the posterior distribution of Ii = 0,1,2 given all other
model parameters and the data. We also propose a MH-move to switch
the group memberships of two SNPs and accept the move based on MH-
ratios. Per MCMC iteration, we first run the Gibbs sampler to update the
memberships of all SNPs once, and then we run the MH-sampler to switch
each SNP in group-1 and group-2 once with SNPs in other groups.
4. Follow-up tests and generalization of the method.
4.1. A test of significance based on the Bayes factor. Although inference
can be directly made from the posterior probabilities output by BEAM2, the
users may want to further evaluate the statistical significance of the results
in a frequentist way. In BEAM [Zhang and Liu (2007)], we developed a novel
Bayes factor, called B-stat, to evaluate whether a SNP or a set of SNPs are
significantly associated with the disease, where the SNP set is selected by
BEAM2 in our case.
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For a set of M SNPs to be tested, the null hypothesis is that all M SNPs
are not associated with the disease. Here, M = 1,2,3, . . . represents single-
SNP, 2-way, and 3-way interactions, etc. B-stat for the set of M SNPs is
defined as
BM = ln
PA(DM ,UM )
P0(DM ,UM )
= ln
P (DM )[P (UM ) +
∏
j∈M P (Uj)]
P (DM ,UM ) +
∏
j∈M P (Dj ,Uj)
.(6)
Here, P0(DM ,UM) denotes the null genotype distribution (i.e., no disease
association) at theM SNPs in cases and controls, and PA(DM ,UM) denotes
the alternative genotype distribution (disease association). Under the null
model, we assume that the genotypes in both cases and controls follow the
same distribution, whereas under the alternative model, they follow different
distributions. We choose both P0(DM ,UM ) and PA(DM ,UM ) as an equal
mixture of two distributions: one that assumes independence among the M
SNPs in controls (and also in cases under the null model), which yields the
product terms in formula (6), and the other that assumes a saturated joint
distribution of all the M SNPs. Note that the form of each term in formu-
la (6) is defined in formula (1).
An interesting feature of B-stat is that it uses a mixture model to ac-
commodate the possibility that the M SNPs may or may not be in linkage
equilibrium (independence). As a result, using B-stat will be more powerful
than using a standard likelihood ratio test or a chi-square test of associations
when the M SNPs under testing are in LD in controls.
We have previously shown that, under the null hypothesis of no disease
association, B-stat follows asymptotically a shifted chi-square distribution
with 3k − 1 degrees of freedom [Zhang and Liu (2007)]. The shifting pa-
rameter can be computed explicitly, which is determined by the sample
size (Nd,Nu), the interaction size M , and the Dirichlet hyper-parameter
{αh}. Briefly speaking, the shifting parameter is proportional to −(3
M −
1) ln(NdNu/(Nd+Nu)), and, thus, the larger the number of individuals col-
lected, or the more SNPs involved in an interaction, the smaller the shifting
parameter will be. In addition, if large hyper-parameters {αh} for the diplo-
type frequency parameters are used, the shifting parameter will be large
too. Note that we want the B-stat to be small (e.g., <0) when the M SNPs
are not associated with the disease, and, hence, the users should use small
values for {αh}, such as the default values we used in our model.
4.2. Generalization to classification problems with discrete covariates. Let
Y be the n×1 binary response vector, and let X= (X1, . . . ,Xp) be the n×p
covariates matrix, with each covariate Xj taking on kj discrete (ordinal or
categorical) values. The standard case–control genetic study setting can be
viewed as using response variables Y (i.e., case–control status) to fish out
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relevant predictors Xj (i.e., SNPs). The epistasis mapping methods BEAM
attempt to find those X’s that interactively affect Y. Both BEAM and the
block-based method BEAM2 can be easily extended to infer a classification
model.
The idea of both BEAM [Zhang and Liu (2007)] and BEAM2 is to parti-
tion the p covariates in X into three nonoverlapping groups, such that one
group contains covariates unrelated with Y, and the other groups contain
covariates either independently or jointly related with Y. The partition of
the covariates is an unobserved latent structure. Given a particular group
partition of the covariates I , we can compute P (X|Y, I) as in Zhang and
Liu (2007), which is analogous to that in a na¨ıve Bayes model. BEAM2 fur-
ther segments the covariates X into “blocks” of highly correlated variables,
and treats blocks as mutually independent. This is achieved by introducing
a block indicator variable B, which is updated iteratively together with the
variable selection indicator I .
To predict the classification of a new observation with covariates xnew
based on the training data (X,Y), we compute P (X,xnew |Y,ynew = 1) and
P (X,xnew |Y,ynew = 0), respectively, using the BEAM (or BEAM2) algo-
rithm, and obtain the odds ratio
P (xnew |X,Y,ynew = 1)/P (xnew |X,Y,ynew = 0).
The prior P (ynew = 1) can be estimated from the prior knowledge of class
distribution, such as the prevalence of a particular disease in the popula-
tion, which then leads to the posterior predictive probability for ynew = 1.
A computationally more attractive way to do the computation is to output
the latent variable partition and block partition structures (I and B in our
case) from their joint posterior distribution inferred by the MCMC proce-
dure of BEAM, and then average the conditional odds over all the sampled I
and B:
P (xnew |X,Y, I,B,ynew = 1)/P (xnew |X,Y, I,B,ynew = 0).
We tested this latter approach in a preliminary study and found the results
quite satisfactory.
The effect of BEAM2 is somewhat analogous to that of elastic net [Zou
and Hastie (2005)] and group lasso [Yuan and Lin (2006)]. All methods at-
tempt to address the phenomena that groups of covariates tend to demon-
strate associations with the response together, and within groups the covari-
ates are highly correlated. Different from elastic net and group lasso, BEAM2
infers the covariate groups and also the informative covariates within groups
jointly in a coherent probability framework. As a consequence, BEAM2 al-
lows sparse variable selection at both the group level and the individual
variable level within groups, whereas elastic net and group lasso do sparse
12 Y. ZHANG, J. ZHANG AND J. S. LIU
selection only at the group level. In a recent technical report, Friedman,
Hastie and Tibshirani (2010) attempt to achieve a similar sparse selection
effect as BEAM2 (sparse selection at both group and individual levels) by
introducing an additional penalty term.
Other important distinctions between BEAM2 (or BEAM) and those
lasso-based methods are the following: (a) the use of the na¨ıve Bayes frame-
work to model X given Y to greatly alleviate the overfitting problem; (b) the
ability to incorporate interaction terms without incurring a huge computa-
tional burden (with MCMC iterations); and (c) the adoption of the Bayesian
variable selection principle, which is equivalent to using a more desirable L0
penalty. The cost of these advantages is that both BEAM and BEAM2
have to compute via MCMC without a guarantee of always finding the opti-
mal solution. Empirically, however, the computational speed of BEAM and
BEAM2 is no worse than that required by lasso-type algorithms when the
number of covariates is large.
5. Simulation studies and algorithm comparisons.
5.1. Block partition of HLA data. We first used the HLA region on hu-
man chromosome 6 to evaluate the block partitions inferred by our method.
The HLA region is one of the few regions in the human genome in which
recombination hotspots have been experimentally verified [Jeffreys, Ritchie
and Neumann (2000); Jeffreys, Kauppi and Neumann (2001)]. We down-
loaded the genotype data of 50 unrelated UK Caucasian semen donors from
Jeffreys AJ’s website. The data covers a 216 kb region with 296 genotyped
biallelic markers spanning from the upstream of gene HLA-DNA to gene
TAP2 in the MHC Class II region. It is known that this region contains
several prominent recombination hotspots [Jeffreys, Ritchie and Neumann
(2000); Jeffreys, Kauppi and Neumann (2001)]. We therefore examined the
relationship between the experimentally verified recombination hotspots and
the SNP-block boundaries inferred by BEAM2. We used both haplotypes
and genotypes to evaluate our method, where the HLA haplotypes were
first inferred by CHB [Zhang, Niu and Liu (2006)] from the genotype data.
We also simulated 1,000 individuals from the inferred HLA haplotypes using
HAPGEN [Marchini et al. (2007)] to evaluate the performance of BEAM2
with a larger sample size. As a comparison, we applied HapBlock [Zhang et
al. (2002b)], a dynamic programming-based algorithm of block partitioning,
to the same sets of data.
With 100 haplotypes inferred from the 50 individuals, BEAM2 produced
accurate block partitions that correspond well to the visual blocks displayed
by Haploview [Barrett et al. (2005)]. The block boundaries also coincide
with the known recombination hotspots within the HLA region (Figure 1).
It is further observed that, for the haplotype data, the blocks inferred by
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Fig. 1. Block partition results on the HLA data. The top panel shows the pairwise SNP
LD calculated from 100 HLA haplotypes by Haploview. The second, third, and forth panels
show the block partition results by BEAM2 (BM) and HapBlock (HB1, HB2, HB3) on
three HLA data sets, respectively. HB1 uses rule 1: common haplotypes; HB2 uses rule 2:
pairwise D′; and HB3 uses rule 3: four-gamete test. Experimentally verified recombination
rates are shown as dashed red lines (the unit cM/Mb in the natural logarithm scale is shown
on the right).
BEAM2 are very similar to those obtained by HapBlock. Unlike our model-
based method, HapBlock requires the user to specify ad hoc block partition
rules, which can result in undesirable partitions. We used three different
rules to define blocks: (1) common haplotypes, defined as a haplotype >5%
in the sample, cover 80% of samples in a block; (2) at least 80% SNP pairs
with D′ > 0.5 in a block; or (3) four-gamete test on common haplotypes
(>5%) in a block. The blocks partitioned by HapBlock using each rule are
also shown in Figure 1.
Using the genotype data of the 50 individuals, we obtained very different
results between BEAM2 and HapBlock, and between the three different
rules of block partitions. Except for the first rule of HapBlock, all other
methods produced a large number of small blocks. Small blocks generated
by BEAM2 are due to the small sample size of 50 individuals, based on which
the correlation between SNPs is hard to detect using our likelihood model.
The posterior probabilities of block boundaries output by BEAM2, however,
can be used as a measure of uncertainty in block partitions. In comparison,
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Table 1
Number of blocks inferred in HLA data sets
Data BEAM2 BEAM2-10p HapBlock-1 HapBlock-2 HapBlock-3
100 haplotypes 32 39 20 30 34
50 genotypes 81 87 46 147 106
1,000 genotypes 35 36 56 184 268
“BEAM2-10p” denotes BEAM2 applying a 10 times larger prior probability than the
default prior on the block boundary variable. HapBlock-1, 2, 3 denotes HapBlock applying
three different block partition rules.
HapBlock and many other block partitioning methods only provide a single
partition solution without measuring block uncertainty.
Using the simulated genotypes of 1,000 individuals, we again observed
very different results shown in Figure 1. BEAM2 produced the cleanest
block partitions that corresponded well to the visual block boundaries and
to the known recombination hotspots. The D′ rule and the four-gamete test
rule via HapBlock again failed to produce reasonable partitions, of which
most blocks were singletons.
We further show in Table 1 the number of blocks inferred by each method
in the three data sets. We observed that BEAM2 performed well (by which
we roughly mean that the number of estimated blocks is small, as is true in
the HLA region) in both the haplotype data and the 1,000 individuals’ geno-
type data. Because modeling genotypes (diplotypes) requires a much larger
set of parameters than modeling haplotypes, BEAM2 is expected to perform
worse in the 50 individuals’ genotype data. As the number of individuals in-
creased to 1,000, however, our model-based approach produced very similar
partitions as that obtained in the haplotype data. In comparison, HapBlock
only preformed reasonably well in the haplotype data, but produced many
small blocks and singletons in the other two data sets for all three block par-
tition rules applied. HapBlock performed the worst in the 1,000 individuals’
genotype data, indicating that the ad hoc rules applied by HapBlock do not
produce consistent block partitions as sample size increases. We further show
in Table 1 additional results by BEAM2 using a 10 times larger prior on the
block boundary variable, that is, we expect 10 times more blocks a priori.
We observed that the estimated posterior number of blocks did not increase
much, particularly in the 1,000 individuals’ genotype data, indicating that
BEAM2 is insensitive to the prior choice of block boundary variables. We
also ran multiple MCMC chains to ensure proper convergence.
5.2. Simulation study using HapMap data. To mimic real genetic data
observed in human populations, we first randomly select a region in the hu-
man genome that contains 1,000 Illumina HapMap 300k tagSNPs. The re-
gion also contains about the same number of additional SNPs from HapMap
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PhaseII tagged by these tagSNPs, which we refer to as nontagging SNPs.
Two nontagging SNPs in the region are randomly selected as disease SNPs.
Given a disease model, we set the marginal effect size (log odds ratio mi-
nus 1) per disease SNP at 0.5 and choose a disease minor allele frequency
(MAF) per locus from (0.05,0.10,0.20,0.50). Given a marginal effect size
and a choice of MAF, we then calculate the diplotype frequencies over the
disease SNPs in cases and controls, respectively [this is similarly done as
presented in Zhang and Liu (2007)]. According to the case–control diplo-
type frequencies over the disease SNPs, we randomly sample 1,000 cases
and 1,000 controls from a pool of individuals without replacement. The
pool consists of 10,000 control individuals generated by HAPGEN [Mar-
chini et al. (2007)] using HapMap European sample (parents only) at odds
ratio = 1, that is, no disease association. Our simulation procedure is more
economical than a direct approach that generates one individual at a time
and determines its disease status conditional on the disease genotypes and
penetrance, because the direct approach may generate many more controls
before obtaining enough cases. Finally, we remove all nontagging SNPs from
the data including the two disease SNPs (which are typically unobserved in
a GWA study), and obtain a case–control data set containing 1,000 Illumina
HapMap tagSNPs.
To evaluate the association mapping performance of our method, we sim-
ulated case–control data sets based on the HapMap sample under three
disease models shown in Table 2. Each disease model assumes 2 loci in the
Table 2
Disease models used in simulation study
Risk A/A A/a a/a
Model 1
B/B 1 1 + θ (1 + θ)2
B/b 1+ θ (1 + θ)2 (1 + θ)3
b/b (1 + θ)2 (1 + θ)3 (1 + θ)4
Model 2
B/B 1 1 1
B/b 1 (1 + θ)2 (1 + θ)3
b/b 1 (1 + θ)3 (1 + θ)4
Model 3
B/B 1 1 1
B/b 1 1 + θ 1+ θ
b/b 1 1 + θ 1+ θ
Each table cell lists the relative risk of the corresponding genotype com-
bination. Genotypes with risks equal to 1 have no effects to the disease.
The parameter θ is computed according to the specified marginal effects
(0.5 in our simulation) and disease MAFs (0.05,0.1,0.2,0.5).
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genome contributing to the disease risk. While the first model assumes no
interactions, the other two models assume different types of interactions.
Using the simulated data sets, we compared the performance of BEAM2 to
BEAM1. We also implemented a third method that maps associations and
interactions based on predetermined block structures. This third method
serves as an intermediate method between BEAM1, which is not block-
based, and BEAM2, which infers block structures and maps associations
simultaneously. We used three different levels of parameters (from stringent
to liberal) to define blocks using existing software, and we treated the diplo-
types within each inferred block as genetic alleles. The third method using
three different block definitions are hereafter referred to as Block1, Block2,
and Block3, respectively [more details of the third method can be found in
the Supplementary Material, Zhang, Zhang and Liu (2011)]. To compare the
performance of all methods, we ranked SNPs according to the association
posterior probabilities output by each method estimated for each data set.
We then calculated how often a method ranked the disease related SNPs
among the top SNPs. A SNP is regarded as being correctly identified as
disease related if it is within 5 SNPs on either side of a true disease locus.
As shown in Figure 2, under all parameter settings, BEAM2 performed the
best among all tested methods, where Block1, Block2, Block3, and BEAM1
all performed similarly. When disease allele frequency was low (f = 0.05),
the power curves of all methods looked similar, but a closer inspection of the
top 5 ranked SNPs showed that BEAM1 only had ∼50% chance to capture
disease related SNPs relative to BEAM2. When disease alleles were common
in the population (f = 0.10,0.20,0.50), the advantage of the BEAM2 model
becomes obvious. Comparing the power curves for Model 2 and Model 3,
we observed that the power of BEAM2 increased much faster than that of
BEAM1 among the top 2 or 3 SNPs. We did not observe this behavior in
Model 1, which has no interactions. It thus indicates that using SNP-blocks
can increase the power of mapping both single SNP and multi-SNP inter-
action associations. All methods compared here are Bayesian methods that
output posterior probabilities of disease associations. It therefore indicates
that our treatment of LD in BEAM2 is more appropriate than using either
predetermined blocks or a Markov chain model (as in BEAM1).
To further declare statistical significance, existing significance estimation
methods adjusting for multiple comparisons should be used, such as the
Bonferroni correction applied to B-stat introduced in BEAM1 [Zhang and
Liu (2007)]. We compared BEAM2 with single SNP chi-square tests using
the above disease models [Supplementary Table S1, Zhang, Zhang and Liu
(2011)], and observed that BEAM2 performed better than the chi-square
test for interaction Model 2 and Model 3, but performed the same for the
noninteractive Model 1.
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Fig. 2. Power comparison for BEAM1, BEAM2, Block1, Block2, and Block3 using sim-
ulated data from the HapMap data. Under each simulation setting and from 50 data sets,
power (y-axis) is calculated as the proportion of disease-associated SNPs (within 5 SNPs
of true disease loci) among top m SNPs (x-axis), ranked by the posterior probability of as-
sociation. Each data set contains 1,000 candidate SNPs in 1,000 cases and 1,000 controls.
The disease allele frequency is 0.05, 0.10, 0.20, and 0.50, respectively. The marginal effect
size of each disease SNP (unobserved) is 0.5. Pink: BEAM1; Red: BEAM2; Blue: Block1;
Green: Block2; Black: Block3.
We also checked the performance of our MCMC sampling algorithm. As
shown in Figure 3, using a simulated data set from disease Model 2, the
lag of autocorrelation of our Markov chain is short, indicating fast conver-
gence of the Markov chain. We further compared the posterior distribution
of SNP associations from 4 independent runs of BEAM2, and we observed
close agreement between runs. In practice, the Markov chain could converge
to local modes, particularly if the data contain many SNPs with complicated
block structures. If block structures are of primary interest, we suggest run-
ning BEAM2 in several runs to check if the block partition results obtained
in different runs are consistent. More advanced MCMC algorithms, such
as parallel tempering [Liu (2001)], could further alleviate the local mode
problems in MCMC sampling.
Using BEAM2, we can estimate the number of disease associated SNPs
around a disease locus by the sum of posterior probabilities of associations
over all SNPs within a neighborhood of a candidate locus. Given our block-
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Fig. 3. Performance of MCMC. (a) Autocorrelation plot obtained by running BEAM2
on a simulated data set of 1,000 cases, 1,000 controls, and 1,000 SNPs under disease Mo-
del 2. A total of 1,000 iterations after burn-in are used to calculate the plot. (b) Posterior
probabilities (in logarithm scale) of disease association (marginal and epistatic) per SNP
compared across 4 independent runs of BEAM2.
based association model, the number of associated SNPs does not include
SNPs whose disease association is merely created by LD, and, hence, our es-
timates are more appropriate than a na¨ıve count of significant SNPs within
the neighborhood. As shown in Figure 4, around a 100-kb neighborhood
of every simulated disease locus in disease Model 1, the estimated number
of disease associated SNPs by BEAM2 is around 1 when the association
signal is sufficiently strong, even if there are many significant SNPs in the
neighborhood. The extra significant SNPs created by LD make the local-
ization of disease locus difficult. This result highlights the importance of
BEAM2 that performs automatic variable selection within blocks. Rather
than reporting diluted small posterior probability of association over many
neighboring SNPs in LD, BEAM2 was able to select the strongest contribut-
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Fig. 4. Estimated number of disease associated SNPs (y-axis) plotted against (a) the
number of significant SNPs (>0.05 family-wise) and (b) the maximum single SNP
chi-square statistics (x-axis) within a 100 kb neighborhood per disease locus. In (a), the
number of loci in each box plot is further shown on the top. The plots are computed from
200 simulated data sets of disease Model 1.
ing SNP within blocks (with large posterior probabilities of association) in
our simulation study.
6. Application to WTCCC type 1 diabetes data. We applied BEAM2
to analyze the T1D data set from the WTCCC project [WTCCC (2007)].
The data set contains 2,000 T1D patients, 1,504 controls from 1958 Birth
Cohort (58C), and 1,500 additional controls from the National Blood Service
(NBS). Given our limited computation resources (computation time, which
would require several days to analyze half a million SNPs in this data set;
and memory usage, which would require >4 Gb for half million SNPs), we
applied BEAM2 to the top 10% SNPs ranked by marginal associations with
T1D on all autosomes. We further filtered out SNPs with bad clustering,
SNPs violating Hardy–Weinberg equilibrium in controls at 10−5 significance,
and “almost nonpolymorphic” SNPs of which >95% samples have the same
genotypes. The final data set contained 42,470 SNPs in 5,004 individuals.
We ran BEAM2 with 5 independent MCMC chains. Figure 5 shows the
averaged posterior probabilities of T1D associations. Note that selecting top
Fig. 5. SNP-wise posterior probabilities (y-axis) of T1D associations in 22 autosomal
chromosomes (x-axis, chromosomes are separated by grey dashed lines). Previously re-
ported T1D associated genes are highlighted in green, and candidate T1D associated genes,
as defined at T1Dbase, are highlighted in red.
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10% SNPs does not imply sparse and less correlated SNPs, because SNPs
in LD tend to be in or out of the top 10% list together. Two alternative
ways to reduce the number of SNPs are to run BEAM2 on each individual
chromosome for chromosome-wise epistasis, or on previously detected disease
associated regions.
6.1. Result summary and highlights. We first compared our results with
the SNPs reported in the original WTCCC paper (2007). As expected, we
found that the SNPs reported by BEAM2 and by the original WTCCC anal-
ysis are highly consistent. All strongly associated SNPs reported in WTCCC
are significant in our analysis, and all strongly and moderately associated
SNPs reported in WTCCC have posterior probability > 0.1 by BEAM2
[Supplementary Table S2, Zhang, Zhang and Liu (2011)]. We further com-
pared our results with known T1D associations obtained from T1Dbase
(www.t1dbase.org). Among the 55 SNPs (or cluster of SNPs) output by
BEAM2 with posterior probabilities greater than 0.1, 17 (31%) overlapped
with known T1D associated regions, including some well-known genes such
as PTPN22 (1p13), CTLA4 (2q33), MHC (6p21), and IL2RA (10p15).
In addition to the previously reported T1D genes, BEAM2 reported some
novel T1D associated loci. A list of likely T1D associations detected by
BEAM2, for both single SNPs (if p-value< 5e−7) and two-way joint asso-
ciations (if p-value < 5e−10), is shown in Tables 3 and 4, respectively. For
example, we detected 7 loci, among which two SNPs in short distance form
strong joint associations with T1D (p-value < 5e−10). These loci are not
identifiable using single SNP tests, but captured by BEAM2 as multi-SNP
Table 3
Strong single SNP associations with T1D
SNP Position p-value T1Dbase Gene
rs6679677∗ chr1: 113.8–114.2 Mb 0 Yes PTPN22
rs9405484 chr6: 1.4 Mb 1.33e−8 No FOXC1
MHC∗ chr6: 25–35 Mb 0 Yes MHC
rs6592988 chr7: 52.1 Mb 2.87e−7 Yes COBL
rs11984645 chr8: 55.2 Mb 7.06e−11 No MRPL15
rs11782342 chr8: 73.9 Mb 5.70e−12 No KCNB2
rs11052552 chr12: 9.7 Mb 2.61e−7 Yes CLEC2D
rs11171739∗ chr12: 54.8 Mb 2.35e−11 Yes ERBB3
rs17696736∗ chr12: 109.8–110.9 Mb 0 Yes CCDC63, NAP1
rs12924729∗ chr16: 11.1 Mb 1.01e−7 Yes CLEC16A
SNPs showing strong associations (p-value< 5e−7) with T1D by single SNP test. p-value:
nominal p-value of associations. T1Dbase: whether the locus is documented in T1Dbase.
Gene: nearest gene.
∗Additional SNPs in its neighborhood also show strong marginal associations.
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Table 4
Strong two-SNP associations with T1D
SNP1 Pos1 Pval1 Gene SNP2 Pos2 Pval2 Gene JointP
rs7525703 chr1: 143 2e−2 PRKAB2 rs2077749 chr1: 143 3e−6 PRKAB2 2e−12
rs6809441 chr3: 41 4e−2 ULK4 N/A chr3: 41 7e−2 ULK4 5e−11
rs330483 chr4: 176 4e−6 ADAM29 rs330504 chr4: 176 1e−1 ADAM29 2e−11
rs6906469 chr6: 10 1e−3 DFCC1 rs659964∗ chr12: 111 2e−6 ACAD10 4e−11
rs3132676∗ chr6: 30 1e−5 TRIM40 rs9376523 chr6: 141 6e−4 TXLNB 3e−11
rs9296661 chr6: 52 4e−4 PKHD1 rs1265566∗ chr12: 110 1e−6 CUTL2 5e−11
rs13340508 chr7: 75 9e−3 CCL24 rs17361077 chr7: 75 4e−5 CCL24 6e−12
rs4838140 chr9: 124 2e−5 NEK6 rs7860360 chr9: 125 6e−4 SCAI 4e−10
rs11104868 chr12: 87 1e−4 KITLG rs7961663∗ chr12: 110 3e−6 CUTL2 1e−11
rs1958305 chr14: 23 5e−5 DHRS2 rs12100601 chr14: 23 2e−2 DHRS2 0
rs7262414 chr20: 40 2e−5 PTPRT rs2867064 chr20: 40 7e−2 PTPRT 0
Pairs of SNPs showing strong joint T1D associations (p-value < 5e−10) by B-stat. If
multiple SNP pairs are located around the same loci, only one pair is shown. Pval1,
Pval2, JointP represent nominal p-values of SNP1, SNP2, and their joint associations,
respectively.
∗SNP lies in known regions in T1Dbase.
associations. We also found some likely long-distance and cross-chromosomal
interaction associations with T1D (p-value < 5e−11). One example is the
joint association between SNP rs3132676 in the classic MHC region on chro-
mosome 6 and SNP rs9376523, which is 111 Mb away on the same chromo-
some. This SNP pair is likely interacting because their genotypes are strongly
correlated in cases (nominal p-value 8e−6 by test of independence), but not
in controls (nominal p-value 0.91). Although most two-way associations did
not pass the Bonferroni adjusted significance level in the genome scale, the
short-distance two-way associations are significant if only considering local
joint associations.
We further examined possible confounding effects of population structures
in the T1D data using a logistic regression model. The regional information
of WTCCC individuals is included as dummy covariates. We observed that
the test statistics of the detected SNP associations remained almost un-
changed before and after the adjustment of population origins. We further
randomly selected 10,000 SNPs genome-wide and compared the distribution
of their association statistics with a chi-square distribution. The two distri-
butions agreed well [see Supplementary Figure S1, Zhang, Zhang and Liu
(2011)]. We therefore believe that population structure does not incur false
positive associations in the WTCCC T1D data.
We finally checked the block partition results of BEAM2 on the T1D data.
Given the large number of SNPs, we cannot visually inspect the blocks as
we did for the HLA data. Alternatively, we computed the genetic distance
between adjacent SNP pairs in the T1D data, using a genetic map con-
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Fig. 6. Frequency (y-axis) of block boundaries between adjacent SNP pairs of certain
genetic distance (x-axis), calculated from the T1D data. The genetic distance is obtained
from the HapMap CEU sample.
structed from the HapMap CEU sample. Then, we checked how frequent
a block boundary is inferred between SNP pairs in certain genetic distance.
Intuitively, the more distant two SNPs are located, the more likely a block
boundary occurs. As shown in Figure 6, our method inferred almost 100%
block boundaries between SNP pairs with genetic distance >1 cM, and the
frequency of block boundary decreases as the SNP pairs get closer. The
block partitions between the 5 runs of BEAM2 are consistent, with an av-
erage correlation coefficient of 0.96.
6.2. Joint association patterns in the MHC region. T1D is an autoim-
mune disease and genes in the MHC region play an important role in the
immune system and autoimmunity [Nejentsev et al. (2007); Steenkiste et
al. (2007)]. BEAM2 found a large number of SNPs within the MHC region
showing extremely strong association signals with T1D. Several multi-locus
joint associations within the MHC region are also detected. We therefore
examined more closely a 10-Mb MHC region, including the extended MHC
region (25–32 Mb) and the classic MHC region (32–35 Mb).
Within this 10 Mb region, we observed that the SNP pairs associated
with T1D are more often strongly correlated in cases than in controls [see
Supplementary Figure S2, Zhang, Zhang and Liu (2011)]. The joint associ-
ations spanned from the classic MHC region to the extended MHC region
over a distance as long as 6.5 Mb. It has been previously reported that hap-
lotype blocks containing the most susceptible alleles HLA-DRB1*03 and
HLA-DRB1*04 within the HLA-DR-DQ region may extend as long as 2 Mb
[Nejentsev et al. (2007)] into the extended MHC region. It is thus arguable
that the joint associations observed between the MHC class II region and
the extended MHC region are due to extensive LD. We used a more tra-
ditional approach, logistic regression, to test two-way interactions among
SNPs within MHC conditioning on the HLA-DR-DQ haplotypes. We first
used CHB [Zhang, Niu and Liu (2006)] to infer haplotypes over HLA-DR-
DQ genes (32.6–32.8 Mb). After collapsing rare haplotypes with frequencies
lower than 0.1% into one group and obtaining 91 groups of haplotypes,
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Fig. 7. Log10 p-values (y-axis) of joint association test between SNPs in the nonclass
II MHC region (x-axis) and SNPs in the MHC class II region (32.5–32.8 Mb), with main
effects of the MHC class II SNPs subtracted and conditioned on 78 T1D associated haplo-
types in HLA-DR-DQ. Each SNP has multiple p-values, shown as grey dots, corresponding
to interactions with different MHC class II SNPs. The black line for the SNP indicates the
− log 10 p-value of the nonclass II SNP’s main effect. A cutoff of 10−5 for the p-values,
shown as the dashed line, corresponds to roughly one false positive among all tests.
we regressed the T1D status on the 91 haplotype groups using 90 dummy
variables, which resulted in 78 significant haplotype groups over the HLA-
DR-DQ genes explaining most of the MHC class II associations with T1D
(the 13 insignificant haplotype groups removed from the model only changed
the model deviance by 9.7).
Conditioning on the 78 haplotype groups, we tested both main and inter-
action effects between pairs of SNPs, one in the nonclass II region (class I,
class III, and the extended MHC region) and one in the class II region. In
particular, we regressed the T1D status on every pair of SNPs and the 78
haplotype groups. The association statistic is the change of deviance before
and after including the two SNPs in the model. We further subtracted the
main effect of the class II SNPs. As shown in Figure 7, we observed sev-
eral peaks of p-values demonstrating significant main and interaction effects
within the nonclass II MHC region. For example, we observed significant
main effects of gene HIST1H2BD at 26.3 Mb (peak of black lines), inter-
action effects of gene PRSS16 at 27.3 Mb and ZNF184 at 27.5 Mb (peaks
of grey dots), strong marginal effects of region 30–31.4 Mb including class I
genes HLA-A and HLA-B (peaks of black lines), and strong interaction ef-
fects of gene BAT1 at 31.6 Mb (peaks of grey dots). The associations of
PRSS16, ZNF184, and BAT1 have been previously reported [Nejentsev et
al. (2007); Viken et al. (2009)], and our analysis further suggested that these
genes are associated with T1D mainly through interactive effects with MHC
class II genes, controlling the MHC class II haplotypes.
7. Discussion. In this article we proposed a model-based Bayesian method
for simultaneous LD-block partitioning and multi-locus epistasis association
mapping. Different from many block-based methods, we combined block
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partitioning and association mapping into a unified Bayesian model, where
both block structures and SNP associations are iteratively learned through
MCMC sampling. For block partitioning, our simulation study and real data
analysis showed that BEAM2 produces accurate and consistent partitions
of SNPs that compared favorably with other genetic knowledge than some
existing methods. The posterior probabilities of block boundaries output
by BEAM2 not only report the most likely block partitions but also mea-
sure the uncertainty of blocks. Compared to some existing methods using
ad hoc partition rules, BEAM2 has two main advantages: (1) it provides
soft partitions rather than hard partitions, that is, it provides a posterior
distribution of block partitions given the data, rather than a single block
partition result; soft partitions are necessary in regions with no dominant re-
combination hotspots and block structures; and (2) it scales up well to large
sample sizes and produces consistent results. In particular, we showed that
our model-based method produces consistent block partitions as the num-
ber of individuals increases, whereas the other methods we tested produced
drastically different results when more individuals from the same population
are included. For association mapping, BEAM2 is more powerful than both
the original BEAM algorithm, which accounts for LD using a Markov chain,
and the methods using pre-estimated blocks. BEAM2 tests disease associa-
tions over uncertain block structures, where most SNPs around disease loci
are filtered out, as their associations are created by LD with nearby disease
SNPs.
The output of BEAM2 is a list of SNP-wise posterior probabilities of
marginal and interaction associations. From a frequentist point of view, the
identified SNPs can be further tested for genome-wide statistical significance.
We previously introduced a Bayes factor-based statistics, B-stat [Zhang and
Liu (2007)], for testing the significance of SNP associations. B-stat performs
similarly to a 2-df chi-square test for single SNPs, but is more powerful for
testing interactions of multiple SNPs. The same B-stat can be used to test
the statistical significance of SNPs selected by the BEAM2 model, as we
demonstrated in this paper.
When applied to the WTCCC T1D data, BEAM2 found all 5 statisti-
cally significant loci previously reported in Table 3 of WTCCC (2007), and
captured 7 moderately (insignificant) associated loci listed in Table 4 of
WTCCC (2007) with nontrivial posterior probabilities (>0.1). BEAM2 fur-
ther reported some novel two-way joint associations, including 7 SNP pairs
(p-value < 5e−10) in short-distance and 4 SNP pairs (p-value < 5e−11) in
long-distance. The local two-way associations indicate main effects of the re-
lated genes, which are, however, not detectable using single SNP tests alone.
The long-distance two-way associations did not pass the genome-wide Bon-
ferroni multiple testing control, but they may be justifiable as real interac-
tion associations if a better multiple testing method is used and a replication
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study is performed. We further analyzed the well-known MHC region, and
our analysis conditioning on the MHC class II haplotypes suggested the ex-
istence of interaction associations rather than MHC extended linkage alone.
Given the complex nature and the important biological role of MHC in the
human genome, our analysis is rather limited. Sophisticated analysis is in
dire need to further reveal the genetic mechanisms underlying MHC and
immune diseases.
The current BEAM model can be further improved in several ways. First,
missing genotypes and unobserved SNPs in the case–control sample can be
treated via imputation [Zhang (2011)]. Previous studies have shown that
imputing untyped SNPs and missing genotypes from a reference panel can
improve the power of disease association mapping [Marchini et al. (2007)].
Second, the current model only reports SNP-wise posterior probabilities of
associations to the disease without providing a detailed analysis of associa-
tion structures of the detected SNPs interactions. We have observed in the
MHC region a bulk of SNPs exhibiting complex association structures with
T1D. A post-analysis of the MHC region is thus needed to delineate fine
structures of the selected SNPs and interactions with respect to their dis-
ease effects and inter-relationships. Third, from a statistical point of view, it
is critical to control the false-discovery rate. This is particularly important
for multi-locus tests, which often involve a much larger number of simulta-
neous comparisons than single SNP tests. We are developing new statistical
methods for evaluating genome-wide statistical significance of associations.
SUPPLEMENTARY MATERIAL
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(DOI: 10.1214/11-AOAS469SUPP; .doc). The file includes a na¨ıve SNP-
block model used in our comparison, verification of population structure
in the sample, LD analysis of the MHC region, Chi-square results of our
simulation study, and comparison of our results with previous results in the
T1D WTCCC1 data.
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